In 2011, in back-to-back papers, Lausch et al. (9) and Briggs et al. (10) described SPENCD to result from biallelic mutations in ACP5, reporting 14 patients from 11 families and 10 patients from eight families, respectively. The gene discussed is ACP5; the disease is Spondyloenchondrodysplasia with immune dysregulation.